Y Intercept Hong Kong Ltd Has $2.96 Million Holdings in Waters Corporation $WAT

Y Intercept Hong Kong Ltd increased its holdings in shares of Waters Corporation (NYSE:WAT) by 271.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,938 shares of the medical instruments supplier’s stock after purchasing an additional 7,263 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Waters were worth $2,960,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Zions Bancorporation National Association UT lifted its position in Waters by 121.2% during the 4th quarter. Zions Bancorporation National Association UT now owns 73 shares of the medical instruments supplier’s stock worth $28,000 after buying an additional 40 shares in the last quarter. Louisbourg Investments Inc. acquired a new stake in shares of Waters in the first quarter valued at about $30,000. First United Bank & Trust acquired a new stake in shares of Waters in the first quarter valued at about $31,000. North Star Investment Management Corp. raised its holdings in Waters by 10,200.0% during the first quarter. North Star Investment Management Corp. now owns 103 shares of the medical instruments supplier’s stock worth $31,000 after acquiring an additional 102 shares in the last quarter. Finally, SHP Wealth Management acquired a new position in Waters during the fourth quarter valued at approximately $32,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Stock Performance

NYSE WAT opened at $374.94 on Wednesday. The stock has a market cap of $36.82 billion, a PE ratio of 47.64, a P/E/G ratio of 2.29 and a beta of 1.20. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.13 and a current ratio of 1.79. The firm has a 50-day moving average of $354.18 and a 200-day moving average of $346.74. Waters Corporation has a 52-week low of $275.05 and a 52-week high of $414.15.

Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $2.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.31 by $0.39. The firm had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.20 billion. Waters had a net margin of 11.91% and a return on equity of 15.60%. The business’s revenue for the quarter was up 91.4% compared to the same quarter last year. During the same period last year, the business posted $2.25 earnings per share. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. On average, sell-side analysts anticipate that Waters Corporation will post 14.51 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on WAT. Wells Fargo & Company boosted their price target on Waters from $355.00 to $370.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 14th. TD Cowen boosted their target price on shares of Waters from $345.00 to $385.00 and gave the stock a “hold” rating in a report on Wednesday, May 6th. HSBC upped their price target on shares of Waters from $415.00 to $435.00 and gave the stock a “buy” rating in a research report on Wednesday, June 3rd. JPMorgan Chase & Co. lifted their price objective on shares of Waters from $330.00 to $345.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Finally, Wolfe Research began coverage on shares of Waters in a research note on Tuesday, June 2nd. They set an “outperform” rating and a $425.00 price objective on the stock. Four investment analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $399.84.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.